Xinjiang Zhongtai Chemical Co Ltd
Xinjiang Zhongtai Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through chemical manufacturing activities.
Business. Xinjiang Zhongtai Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through chemical manufacturing activities.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Xinjiang Zhongtai Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through chemical manufacturing activities.
The company exhibits a leveraged capital structure with a debt-to-equity ratio of 1.84, indicating significant reliance on debt financing relative to equity. Liquidity is constrained, evidenced by a current ratio of 0.45, which suggests potential short-term solvency pressures. Despite negative net income of -288.75 million CNY, the company generated positive operating cash flow of 3.25 billion CNY, though free cash flow remained negative at -569.60 million CNY due to capital expenditures of 2.98 billion CNY. The market capitalization of 10.10 billion CNY reflects a price-to-book ratio of 0.47, trading at a discount to tangible book value.
Profitability metrics are currently negative, with a return on equity of -4.13% and a return on assets of -1.16%, reflecting operational losses in the latest period. The company reported an operating income of -118.72 million CNY on revenues of 28.70 billion CNY, resulting in a gross profit of 5.27 billion CNY. Without cohort median data for direct comparison, the negative returns indicate a period of financial stress or cyclical downturn within the chemical manufacturing sector. The enterprise value to EBITDA ratio is negative at -55.08, further highlighting the current unprofitability.
Segment and geographic revenue breakdowns are not provided in the available data, preventing analysis of revenue concentration or specific business unit performance. The company's primary activity is identified as unclassified within the broader chemicals industry, limiting detailed operational insights.
Growth trajectory analysis is hindered by the absence of historical period data, preventing assessment of revenue or net income trends over time. The current financial snapshot shows a single period of negative net income, but without historical context, the direction of growth cannot be determined.
Risk assessment indicates medium liquidity risk and low dilution risk, with a key flag noting that net cash is negative after subtracting total debt. The company's total liabilities of 55.27 billion CNY exceed its total assets of 76.79 billion CNY, but the negative net cash position highlights potential refinancing or liquidity challenges. The current ratio of 0.45 reinforces the medium liquidity risk classification.
Recent observations include an ESG score of 50.87 with a grade of B-, indicating moderate environmental, social, and governance performance. The environment pillar score is 56.48, while the social and governance pillars are 43.51 and 53.43, respectively. The ESG controversies score is 100, suggesting no significant recent controversies. No specific filing, news, or transcript observations are provided in the available data.
- The company trades at a significant discount to book value with a P/B ratio of 0.47, reflecting market skepticism about current profitability.
- High leverage with a debt-to-equity ratio of 1.84 and a low current ratio of 0.45 indicate elevated financial risk.
- Positive operating cash flow of 3.25 billion CNY contrasts with negative free cash flow due to high capital expenditures.
- Negative returns on equity and assets highlight current operational inefficiencies or cyclical headwinds.
- Low dilution risk suggests stable share count, but liquidity risk remains medium due to negative net cash.
Bull / Bear case
Generated · model-assistedGross profit remained positive at 5.3 billion CNY in the latest period, indicating underlying production value despite operating losses.
Revenue stabilized with a 5.0% year-over-year increase in the latest period, suggesting potential bottoming of top-line decline.
Dilution risk is assessed as low, providing some protection for existing shareholders against equity value erosion.
The company posted a net loss of 976.5 million CNY in the latest period, reflecting severe profitability deterioration.
Free cash flow turned deeply negative at -1.87 billion CNY, signaling significant liquidity pressure and cash burn.
Long-term debt surged to 35.1 billion CNY, creating a high credit risk profile and heavy leverage burden.
In focus — financials by report
Revenue ¥37.12B, −28,1% YoY; Operating income −313,1% YoY.
- ▍Revenue ¥37.12B, −28,1% YoY
- ▍Operating income −313,1% YoY
- ▍Net income −469,1% YoY
- ▍Free cash flow −113,2% YoY
- ▍Net margin -7.7%
Revenue ¥51.66B, −17,9% YoY; Operating income −59,2% YoY.
- ▍Revenue ¥51.66B, −17,9% YoY
- ▍Operating income −59,2% YoY
- ▍Net income −71,8% YoY
- ▍Free cash flow −204,8% YoY
- ▍Net margin 1.5%
Revenue ¥62.89B; Operating income ¥3.63B.
- ▍Revenue ¥62.89B
- ▍Operating income ¥3.63B
- ▍Net margin 4.4%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Xinjiang Zhongtai Chemical Co Ltd Market data — financials · 2026-07-08
- Xinjiang Zhongtai Chemical Co Ltd Market data — ESG · 2026-07-08